AsadBasheyMD

Hematology • Atlanta, GA

Hematologic Oncology, Myeloproliferative Disorder Hematology-Oncology

Director of Clinical Research for The Blood and Marrow Transplant Program at Northside Hospital.

Join to view full profile

Dr. Bashey is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Bashey's full profile

Already have an account?

Office
5670 Peachtree Dunwoody Rd Ne
Suite 1000
Atlanta, GA 30342
Phone+1 404-255-1930

Fax+1 404-459-8510
Is this information wrong?

Education & Training

University of California (San Diego) Medical CenterFellowship, Hematology and Medical Oncology, 1993 - 1996
Univ Dundee- Fac MedClass of 1984

Certifications & Licensure

GA State Medical License 2005 - 2025
CA State Medical License 1994 - 2024
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Atlanta Magazine: Top Doctors Castle Connolly, 2013-2014, 2014-2022

Clinical Trials

Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer Start of enrollment: 2002 Dec 01
Completed
Phase 2
Fludarabine-based Conditioning for Severe Aplastic Anemia (BMT CTN 0301) Start of enrollment: 2006 Jan 01
Completed
Phase 1, Phase 2
Combination 5-azacitidine and Gemtuzumab Ozogamicin Therapy for Treatment of Relapsed Acute Myeloid Leukemia (AML) Start of enrollment: 2005 Jul 01
Completed
Phase 1, Phase 2
Combination Chemotherapy, Donor Stem Cell Transplant, Tacrolimus, Mycophenolate Mofetil, and Cyclophosphamide in Treating Patients With Hematologic Cancer Start of enrollment: 2008 Oct 01
Completed
Phase 2
Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer Start of enrollment: 2007 Apr 01
Completed
Phase 2
Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702) Start of enrollment: 2010 May 01
Completed
Phase 3
Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant Start of enrollment: 2010 Dec 01
Terminated
Phase 2
Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant Start of enrollment: 2011 Apr 20
Completed
Phase 3
Total Body Irradiation/Fludarabine Based Ablative Haploidentical Transplant for Hematologic Diseases Start of enrollment: 2011 Apr 01
Completed
Phase 2
Palonosetron, Ondansetron, and Dexamethasone for Delayed Nausea and Vomiting in Autologous Transplant Patients Start of enrollment: 2012 Feb 01
Completed
Phase 2
Phase 1/2, Open-label, Dose-escalation Study of IONIS-STAT3Rx, Administered to Patients With Advanced Cancers Start of enrollment: 2012 Feb 27
Completed
Phase 1, Phase 2
Ipilimumab or Nivolumab in Treating Patients With Relapsed Hematologic Malignancies After Donor Stem Cell Transplant Start of enrollment: 2013 May 16
Completed
Phase 1
Nonmyeloablative Haploidentical Transplant Followed by MLN9708 Start of enrollment: 2014 Jul 15
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

Revised HLA-DP TCE-Core Permissiveness Model Better Defines Relapse Risk and Survival Following Haploidentical Transplant.
Michael T Aubrey, Katelin C Jackson, Xu Zhang, Christina L Roark, H Kent Holland, Scott R Solomon, Lizamarie Bachier-Rodriguez, Melhem M Solh, Lawrence E Morris, Asad ...> ;Transplantation and Cellular Therapy. 2024 Mar 30
Immunosuppression-Free Status at 1 Year after Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide.
Xu Zhang, H Kent Holland, Lizamarie Bachier-Rdriguez, Lawrence E Morris, Scott R Solomon, Melhem Solh, Asad Bashey> ;Transplantation and Cellular Therapy. 2024 Mar 27
Galectin-3 predicts acute GvHD and overall mortality post reduced intensity allo-HCT: a BMT-CTN biorepository study.
Philip L McCarthy, Kristopher M Attwood, Xiaojun Liu, George L Chen, Hans Minderman, Amin Alousi, Asad Bashey, Robert Lowsky, David B Miklos, John Hansen, Peter Wester...> ;Bone Marrow Transplantation. 2024 Mar 1
2 citations
Phase 1 study of vibecotamab identifies an optimized dose for treatment of relapsed/refractory acute myeloid leukemia.
Farhad Ravandi, Asad Bashey, James Foran, Wendy Stock, Raya Mawad, Nicholas Short, Musa Yilmaz, Hagop Kantarjian, Olatoyosi Odenike, Anand Patel, Raman Garcha, William...> ;Blood Advances. 2023 Nov 14
3 citations
Phase 2 study of PD-1 blockade following autologous transplantation for patients with AML ineligible for allogeneic transplant.
Scott R Solomon, Melhem Solh, Lawrence E Morris, H Kent Holland, Lizamarie Bachier-Rodriguez, Xu Zhang, Caitlin Guzowski, Katelin C Jackson, Stacey Brown, Asad Bashey> ;Blood Advances. 2023 Sep 26
3 citations
Hematopoietic stem cell mobilization for allogeneic stem cell transplantation by motixafortide, a novel CXCR4 inhibitor.
Zachary D Crees, Michael P Rettig, Asad Bashey, Steven M Devine, Samantha Jaglowski, Fei Wan, Amy Zhou, Melinda Harding, Abi Vainstein-Haras, Ella Sorani, Irit Gliko-K...> ;Blood Advances. 2023 Sep 26
2 citations
A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysis.
Roni Tamari, Donal P McLornan, Kwang Woo Ahn, Noel Estrada-Merly, Juan Carlos Hernández-Boluda, Sergio Giralt, Jeanne Palmer, Robert Peter Gale, Zachariah DeFilipp, Da...> ;Blood Advances. 2023 Aug 8
3 citations
Improved access to HCT with reduced racial disparities through integration with leukemia care and haploidentical donors.
Asad Bashey, Xu Zhang, Lawrence E Morris, H K Holland, Lizamarie Bachier-Rodriguez, Scott R Solomon, Melhem Solh> ;Blood Advances. 2023 Aug 8
Haploidentical Donor Blood or Marrow Transplantation for Myelodysplastic/Myeloproliferative Overlap Neoplasms: Results from a North American Collaboration.
Tania Jain, Hua-Ling Tsai, Hany Elmariah, Pankit Vachhani, Theodoros Karantanos, Sarah Wall, Lukasz Gondek, Asad Bashey, Alla Keyzner, Roni Tamari, Michael Grunwald, S...> ;Research Square. 2023 Mar 21
1 citations
Extracorporeal photopheresis (ECP) improves overall survival in the treatment of steroid refractory acute graft-versus-host disease (SR aGvHD).
Melhem M Solh, Chloe Farnham, Scott R Solomon, Asad Bashey, Lawrence E Morris, H Kent Holland, Xu Zhang> ;Bone Marrow Transplantation. 2023 Feb 1
18 citations
Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naïve settings.
Jacqueline S Garcia, Yael Flamand, Livius Penter, Michael Keng, Benjamin K Tomlinson, Lourdes M Mendez, Paul Koller, Nicole Cullen, Yohei Arihara, Kathleen Pfaff, Jacq...> ;Blood. 2023 Apr 13
2 citations
Lineage-Specific Relapse Prediction After Haploidentical Transplantation With Post-Transplant Cyclophosphamide Based on Recipient HLA-B-Leader Genotype and HLA-C-Group...
Scott R Solomon, Michael T Aubrey, Xu Zhang, Katelin C Jackson, Christina L Roark, Brian M Freed, Lawrence E Morris, H Kent Holland, Melhem M Solh, Asad Bashey> ;Transplantation and Cellular Therapy. 2022 Sep 1
3 citations
High-Dose Bendamustine, Etoposide, Cytarabine, and Melphalan (BeEAM) Conditioning Before Autologous Transplantation for Patients With Multiple Myeloma.
Scott R Solomon, Stacey Brown, Nancy Shegda, Katelin C Jackson, Xu Zhang, Asad Bashey, H Kent Holland, Lawrence E Morris, Melhem Solh> ;Transplantation and Cellular Therapy. 2022 Aug 1
11 citations
Trajectories of quality of life recovery and symptom burden after autologous hematopoietic cell transplantation in multiple myeloma.
Anita D'Souza, Ruta Brazauskas, Edward A Stadtmauer, Marcelo C Pasquini, Parameswaran Hari, Asad Bashey, Natalie Callander, Steven Devine, Yvonne Efebera, Siddhartha G...> ;American Journal of Hematology. 2023 Jan 1
9 citations
Title: Impact of Induction Therapy with VRD vs. VCD on Outcomes in Patients with Multiple Myeloma in Partial Response or Better Undergoing Upfront Autologous Stem Cell...
Surbhi Sidana, Shaji Kumar, Raphael Fraser, Noel Estrada-Merly, Sergio Giralt, Vaibhav Agrawal, Larry D. Anderson, Mahmoud Aljurf, Rahul Banerjee, Asad Bashey, Minoo B...> ;Transplantation and Cellular Therapy. 2021 Nov 12
43 citations
HLA Informs Risk Predictions after Haploidentical Stem Cell Transplantation with Post-transplantation Cyclophosphamide.
Ephraim J. Fuchs, Shannon R. McCurdy, Scott R. Solomon, Tao Wang, Megan M. Herr, Dipenkumar Modi, Michael R. Grunwald, Taiga Nishihori, Michelle Kuxhausen, Stephanie F...> ;Blood. 2021 Nov 1
23 citations
Allogeneic blood or marrow transplantation with haploidentical donor and post-transplantation cyclophosphamide in patients with myelofibrosis: a multicenter study
Siddharth Kunte, Lisa Rybicki, Auro Viswabandya, Roni Tamari, Asad Bashey, Alla Keyzner, Madiha Iqbal, Michael R. Grunwald, Bhagirathbhai Dholaria, Hany Elmariah, Mich...> ;Leukemia. 2021 Oct 18
33 citations
Haploidentical vs. sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia.
Matthew J Wieduwilt, Leland Metheny, Mei-Jie Zhang, Hai-Lin Wang, Noel Estrada-Merly, David I. Marks, A Samar Al-Homsi, Lori Muffly, Nelson J. Chao, David A. Rizzieri,...> ;Blood Advances. 2021 Sep 21
9 citations
Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic Syndromes
Betul Oran, Kwang Woo Ahn, Caitrin Fretham, Amer Beitinjaneh, Asad Bashey, Attaphol Pawarode, Baldeep Wirk, Bart L. Scott, Bipin N. Savani, Christopher Bredeson, Danie...> ;Transplantation and Cellular Therapy. 2021 Aug 14
Correction to: Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era.
Dhakal, B., Patel, S., Girnius, S., Bachegowda, L., Fraser, R., Davila, O., Kanate, A., Assal, A., Hanbali, A., Bashey, A., Pawarode, A., Freytes, C., Lee, C., Vesole,...> ;Leukemia. 2021 Jul 1
12 citations
Incidence and impact of community respiratory viral infections in post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis and haploidentical stem ...
Carolyn Mulroney, Muhammad Bilal Abid, Asad Bashey, Roy F. Chemaly, Stefan O. Ciurea, Min Chen, Christopher E. Dandoy, Miguel Pérez, Brian D. Friend, Ephraim J. Fuchs,...> ;British Journal of Haematology. 2021 Jul 1
69 citations
Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysis
Abid, M. B., Scott R. Goldsmith, Muhammad Bilal Abid, Jeffery J. Auletta, Asad Bashey, Amer Beitinjaneh, Paul Castillo, Roy F. Chemaly, Min Chen, Stefan O. Ciurea, Chr...> ;Blood. 2021 Jun 10
3 citations
A Phase II Trial of Melphalan Based Reduced-Intensity Conditioning for Transplantation of T-Replete HLA-Haploidentical Peripheral Blood Stem Cells with Posttransplant ...
Melhem Solh, Gabriel Hinojosa, Justin LaPorte, Scott R. Solomon, Lawrence E. Morris, Xu Zhang, H. Kent Holland, Asad Bashey> ;Advances in Hematology. 2021 Mar 23
42 citations
Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma
Reid W. Merryman, Luca Castagna, Laura Giordano, Vincent T. Ho, Paolo Corradini, Anna Guidetti, Beatrice Casadei, David A. Bond, Samantha Jaglowski, Michael A. Spinner...> ;Leukemia. 2021 Mar 3
12 citations
Impact of Pretransplantation Renal Dysfunction on Outcomes after Allogeneic Hematopoietic Cell Transplantation
Nosha Farhadfar, Ajoy Dias, Tao Wang, Caitrin Fretham, Saurabh Chhabra, Hemant S. Murthy, Larisa Broglie, Anita D'Souza, Shahinaz M. Gadalla, Robert Peter Gale, Shahru...> ;Transplantation and Cellular Therapy. 2021 May 1
Join now to see all

Journal Articles

The European Society for Blood and Marrow Transplantation (EBMT) Consensus Recommendations for Donor Selection in Haploidentical Hematopoietic Cell Transplantation
Leo Luznik, Karen Ballen, Asad Bashey, Hillard M Lazarus, Bipin N Savani, Rizwan Romee, Ephraim J Fuchs, Nature

Abstracts/Posters

Allogeneic Transplantation for Myelodysplastic Syndrome in Adults over 50 Years Old Using Reduced Intensity/Non-Myeloablative Conditioning: Haploidentical Relative Ver...
Asad Bashey, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Psychological and Social Factors Are a Strong Predictor of Survival after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Independent of Disease Risk and Mor...
Asad Bashey, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
A Phase II Trial of Melphalan Based Reduced Intensity Conditioning and Transplantation of Partially HLA-Mismatched Peripheral Blood Stem Cells for Patients with Hemato...
Asad Bashey, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Ixazomib Maintenance to Prevent Alloreactivity and Provide Anti-Malignancy Effects Following Nonmyeloablative T-Replete Haploidentical Peripheral Blood Stem Cell Trans...
Asad Bashey, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Safety and Efficacy of Allogeneic Hematopoietic Stem Cell Transplant after Programmed Cell Death 1 (PD-1) / Programmed Cell Death Ligand 1 (PD-L1) Blockade for Classic...
Asad Bashey, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Graft Versus Host Disease (GVHD) after HLA-Mismatched Haploidentical Transplantation with Post-Transplant Cyclophosphamide Compared to Matched Unrelated Donor: Inciden...
Asad Bashey, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Reduced Toxicity Conditioning for Non-Malignant Hematopoietic Cell Transplants
Asad Bashey, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Real World Outcomes of Letermovir Prophylaxis in Unselected High Risk CMV Seropositive Hematopoietic Stem Cell Transplant Recipients
Asad Bashey, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Join now to see all

Lectures

Improved Survival in Patients Who Undergo Relapse of Acute Myeloid Leukemia Following Allogeneic Hematopoietic Cell Transplantation
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Improved Survival of Patients Diagnosed with Severe (Grade 3-4) Acute GVHD or Severe NIH Grade Chronic GVHD in the Current Era Compared to Historic Controls
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Evaluation of Romyelocel-L Myeloid Progenitor Cells to Decrease Infections in De Novo AML Patients Receiving High-Dose Ara-C-Based Induction Therapy
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Phase II Study Evaluating the Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem and Progenitor Cells for Allogeneic Hematopoietic Cell Tr...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
The Choice of Induction Regimen Affects Post Remission Survival of Acute Myelogenous Leukemia (AML) Patients with Intermediate or Poor Risk Disease
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Join now to see all